These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 17368903

  • 1. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ.
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [Abstract] [Full Text] [Related]

  • 2. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.
    Mouridsen HT.
    Curr Med Res Opin; 2006 Aug; 22(8):1609-21. PubMed ID: 16870085
    [Abstract] [Full Text] [Related]

  • 3. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
    Coleman RE, Bolten WW, Lansdown M, Dale S, Jackisch C, Merkel D, Maass N, Hadji P.
    Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
    [Abstract] [Full Text] [Related]

  • 4. Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective.
    Garreau JR, Delamelena T, Walts D, Karamlou K, Johnson N.
    Am J Surg; 2006 Oct; 192(4):496-8. PubMed ID: 16978958
    [Abstract] [Full Text] [Related]

  • 5. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R.
    Eur J Surg Oncol; 2008 Jul; 34(7):746-55. PubMed ID: 18296017
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adjuvant hormonal therapy in peri- and postmenopausal breast cancer.
    Ryan PD, Goss PE.
    Oncologist; 2006 Jul; 11(7):718-31. PubMed ID: 16880231
    [Abstract] [Full Text] [Related]

  • 8. Menopausal symptoms and adjuvant therapy-associated adverse events.
    Hadji P.
    Endocr Relat Cancer; 2008 Mar; 15(1):73-90. PubMed ID: 18310277
    [Abstract] [Full Text] [Related]

  • 9. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G.
    Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
    Cella D, Fallowfield LJ.
    Breast Cancer Res Treat; 2008 Jan; 107(2):167-80. PubMed ID: 17876703
    [Abstract] [Full Text] [Related]

  • 12. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    Lintermans A, Vanderschueren D, Verhaeghe J, Van Asten K, Jans I, Van Herck E, Laenen A, Paridaens R, Billen J, Pauwels S, Vermeersch P, Wildiers H, Christiaens MR, Neven P.
    Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
    [Abstract] [Full Text] [Related]

  • 13. Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms?
    Muslimani AA, Spiro TP, Chaudhry AA, Taylor HC, Jaiyesimi I, Daw HA.
    Clin Breast Cancer; 2009 Feb; 9(1):34-8. PubMed ID: 19299238
    [Abstract] [Full Text] [Related]

  • 14. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
    Chlebowski RT.
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():25-34. PubMed ID: 19101792
    [Abstract] [Full Text] [Related]

  • 15. Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer.
    Dent SF, Gaspo R, Kissner M, Pritchard KI.
    Breast Cancer Res Treat; 2011 Apr; 126(2):295-310. PubMed ID: 21249443
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant endocrine therapy for early breast cancer.
    Andreetta C, Smith I.
    Cancer Lett; 2007 Jun 18; 251(1):17-27. PubMed ID: 17150303
    [Abstract] [Full Text] [Related]

  • 17. Effectively nursing patients receiving aromatase inhibitor therapy.
    Wengström Y.
    Breast; 2008 Jun 18; 17(3):227-38. PubMed ID: 18077168
    [Abstract] [Full Text] [Related]

  • 18. Safety of adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Abdulhaq H, Geyer C.
    Am J Clin Oncol; 2008 Dec 18; 31(6):595-605. PubMed ID: 19060594
    [Abstract] [Full Text] [Related]

  • 19. Translating trial data into patients benefits: making the right choice.
    Chlebowski RT.
    Breast; 2008 Apr 18; 17 Suppl 3():S9-15. PubMed ID: 18367397
    [Abstract] [Full Text] [Related]

  • 20. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK, Nielsen DL, Lindberg H, Kamby C.
    Ugeskr Laeger; 2007 Jan 22; 169(4):297-9. PubMed ID: 17274922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.